SYRS logo

Syros Pharmaceuticals (SYRS) Long Term Debt

Annual Long Term Debt

$53.08 M
-$8.42 M-13.68%

December 31, 2023


Summary


Performance

SYRS Long Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSYRSbalance sheetmetrics:

Quarterly Long Term Debt

$57.64 M
-$524.00 K-0.90%

September 30, 2024


Summary


Performance

SYRS Quarterly Long Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSYRSbalance sheetmetrics:

Long Term Debt Formula

Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt

SYRS Long Term Debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-13.7%-1.6%
3 y3 years-17.7%-3.0%
5 y5 years+10000.0%-3.0%

SYRS Long Term Debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-16.0%at low-8.8%+21.1%
5 y5-year-17.7%+115.5%-10.6%+133.9%
alltimeall time-17.7%-100.0%-10.6%>+9999.0%

Syros Pharmaceuticals Long Term Debt History

DateAnnualQuarterly
Sep 2024
-
$57.64 M(-0.9%)
Jun 2024
-
$58.17 M(+22.2%)
Mar 2024
-
$47.59 M(-10.3%)
Dec 2023
$53.08 M(-13.7%)
$53.08 M(-9.3%)
Sep 2023
-
$58.55 M(-3.5%)
Jun 2023
-
$60.66 M(+2.1%)
Mar 2023
-
$59.41 M(-3.4%)
Dec 2022
$61.50 M(-2.7%)
$61.50 M(-0.6%)
Sep 2022
-
$61.90 M(+10.8%)
Jun 2022
-
$55.86 M(-8.7%)
Mar 2022
-
$61.16 M(-3.2%)
Dec 2021
$63.18 M(-2.0%)
$63.18 M(-0.5%)
Sep 2021
-
$63.53 M(-0.5%)
Jun 2021
-
$63.85 M(-0.5%)
Mar 2021
-
$64.17 M(-0.5%)
Dec 2020
$64.48 M
$64.48 M(+42.9%)
Sep 2020
-
$45.11 M(-0.8%)
Jun 2020
-
$45.47 M(+2.5%)
DateAnnualQuarterly
Mar 2020
-
$44.37 M(+80.1%)
Dec 2019
$24.64 M(>+9900.0%)
$24.64 M(+29.2%)
Sep 2019
-
$19.07 M(+12.5%)
Jun 2019
-
$16.95 M(+1007.4%)
Mar 2019
-
$1.53 M(+6859.1%)
Dec 2018
$22.00 K(+266.7%)
$22.00 K(-8.3%)
Sep 2018
-
$24.00 K(-11.1%)
Jun 2018
-
$27.00 K(+440.0%)
Mar 2018
-
$5000.00(-16.7%)
Dec 2017
$6000.00(-88.7%)
$6000.00(-14.3%)
Sep 2017
-
$7000.00(-12.5%)
Jun 2017
-
$8000.00(-11.1%)
Mar 2017
-
$9000.00(-83.0%)
Dec 2016
$53.00 K(-74.3%)
$53.00 K(-44.8%)
Sep 2016
-
$96.00 K(-30.4%)
Jun 2016
-
$138.00 K(-16.9%)
Mar 2016
-
$166.00 K(-19.4%)
Dec 2015
$206.00 K(>+9900.0%)
$206.00 K
Dec 2014
$0.00
-

FAQ

  • What is Syros Pharmaceuticals annual long term debt?
  • What is the all time high annual long term debt for Syros Pharmaceuticals?
  • What is Syros Pharmaceuticals annual long term debt year-on-year change?
  • What is Syros Pharmaceuticals quarterly long term debt?
  • What is the all time high quarterly long term debt for Syros Pharmaceuticals?
  • What is Syros Pharmaceuticals quarterly long term debt year-on-year change?

What is Syros Pharmaceuticals annual long term debt?

The current annual long term debt of SYRS is $53.08 M

What is the all time high annual long term debt for Syros Pharmaceuticals?

Syros Pharmaceuticals all-time high annual long term debt is $64.48 M

What is Syros Pharmaceuticals annual long term debt year-on-year change?

Over the past year, SYRS annual long term debt has changed by -$8.42 M (-13.68%)

What is Syros Pharmaceuticals quarterly long term debt?

The current quarterly long term debt of SYRS is $57.64 M

What is the all time high quarterly long term debt for Syros Pharmaceuticals?

Syros Pharmaceuticals all-time high quarterly long term debt is $64.48 M

What is Syros Pharmaceuticals quarterly long term debt year-on-year change?

Over the past year, SYRS quarterly long term debt has changed by -$908.00 K (-1.55%)